Company description

Experienced in the development and manufacture of oral dosage forms for cardiovascular, gastrointestinal, endocrine, CNS conditions and infectious diseases. Our manufacturing facilities are equipped to produce over 3 billion immediate and controlled release tablets and capsules yearly.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Primary business activity Manufacturer
Affiliated categories: Capsules |Contract Manufacturing |Contract Packaging More

Upcoming events

9 sep 2020

CPhI North America 2020

9 - 11 Sep 2020 Philadelphia, USA Visit us at stand 1318 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

30 apr 2019

CPhI North America 2019

30 April - 2 May 2019 Chicago, USA We were at stand 2037 See our Exhibitor Profile   See full Exhibitor List
Frontida BioPharm

Contact information




View all contact information